Your browser doesn't support javascript.
loading
Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case series.
Ruberti, Andrea; Kremer Hovinga, Johanna A; Nappi, Federico; Vettese, Aurora; Bianchi, Elena; Fernandes, Eliana; Galfetti, Elena; Monotti, Rita; Paul, Pamella; Regazzoni, Stefano; Valente, Daniela; Rossi, Davide; Stussi, Georg; Gerber, Bernhard.
Affiliation
  • Ruberti A; Department of Internal Medicine, Ospedale La Carità, Locarno, Switzerland.
  • Kremer Hovinga JA; Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland.
  • Nappi F; Department of Haematology and Central Haematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Vettese A; Department of Internal Medicine, Ospedale La Carità, Locarno, Switzerland.
  • Bianchi E; Department of Laboratory Medicine EOLAB, Bellinzona, Switzerland.
  • Fernandes E; Clinic of Haematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Galfetti E; Clinic of Haematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Monotti R; Clinic of Haematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Paul P; Department of Internal Medicine, Ospedale La Carità, Locarno, Switzerland.
  • Regazzoni S; Clinic of Haematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Valente D; Department of Internal Medicine, Ospedale Civico, Lugano, Switzerland.
  • Rossi D; Private practice, Chiasso, Switzerland.
  • Stussi G; Clinic of Haematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Gerber B; Laboratory of Experimental Haematology, Institute of Oncology Research, Bellinzona, Switzerland.
Swiss Med Wkly ; 153: 40048, 2023 03 31.
Article in En | MEDLINE | ID: mdl-37021783
AIMS OF THE STUDY: Acquired haemophilia A is a rare disease with an annual incidence of 1.48 per million. Based on clinical observations, we suspect a higher incidence in southern Switzerland, and aimed at providing local epidemiological data, and clinical information regarding diagnosis, treatment and outcome in our region. METHODS: All adult patients with acquired haemophilia A treated between 2013 and 2019 in our facility were included in the present retrospective analysis. RESULTS: We treated 11 patients with acquired haemophilia A between 2013 and 2019, resulting in an annual incidence of 4.5 per million (95% confidence interval [CI] 0-9.0). Median delay from first symptoms to diagnosis was 4.5 days, and the median age at diagnosis was 79 years (range 23-87). Possible causative conditions were: pregnancy (n = 1), polyarteritis nodosa (n = 1), myelodysplastic syndrome (n = 1), chronic human immunodeficiency virus (HIV) (n = 1), and HIV postexposure prophylaxis (n = 1). In five patients no underlying or associated condition was identified. Median activated partial thromboplastin time (aPTT)) at baseline was 79 seconds (65-117; ref. value <38 sec), and FVIII:C 2.15% (<1-3.75%). A FVIII:C <1% was present in 4/10 patients. Median FVIII-inhibitor titre was 10.3 BU/ml (2.4-75.0 BU/ml). All patients had bleeding symptoms, 5/10 patients had major bleedings, and 7/10 patients were treated with bypassing agents. All patients received corticosteroids; 7/10 patients received immunosuppressive combination therapy. FVIII levels of ≥50% were achieved after a median of 40 days (8-62). One patient had a severe immunosuppressive therapy-related infection. An 87-years-old woman died for reasons not related to acquired haemophilia A or immunosuppressive therapy. CONCLUSIONS: Acquired haemophilia A is a rare disease, but manageable despite the advanced patient age and comorbidities. Its incidence in Southern Switzerland is higher than previously suspected.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemophilia A Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged / Pregnancy Country/Region as subject: Europa Language: En Journal: Swiss Med Wkly Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemophilia A Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged / Pregnancy Country/Region as subject: Europa Language: En Journal: Swiss Med Wkly Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland